Related Experiment Videos
Adjustment for competing risk in kin-cohort estimation.
Nilanjan Chatterjee1, Patricia Hartge, Sholom Wacholder
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20852, USA. chattern@mail.nih.gov
Genetic Epidemiology
|November 26, 2003
Summary
This study introduces a new method for kin-cohort studies to estimate the risk of multiple related health events, like cancers, from genetic mutations. The approach uses a competing risk framework to provide more accurate risk assessments for carriers and noncarriers.
Area of Science:
- Genetics and Epidemiology
- Statistical Genetics
- Cancer Epidemiology
Background:
- Kin-cohort studies analyze genetic mutation risks across relatives.
- Existing methods struggle with multiple, related events and censoring.
- Bias in risk estimation arises when events are interconnected and influence follow-up.
Purpose of the Study:
- To develop a statistical framework for kin-cohort studies to estimate risks of multiple, competing events.
- To address limitations of current methods that assume independence of censoring events.
- To accurately assess the cause-specific hazard functions for genetic mutation carriers and noncarriers.
Main Methods:
- Utilized a competing risk framework to model multiple event occurrences.
- Proposed an extension of a previously developed composite-likelihood approach for estimation.
- Applied the method to estimate ovarian cancer risk from BRCA1/2 mutations, excluding breast cancer cases.
Main Results:
- Demonstrated that cause-specific hazard functions are identifiable from kin-cohort data within the competing risk framework.
- The proposed composite-likelihood extension provides a viable estimation method.
- Successfully illustrated the method's application using data from the Washington Ashkenazi Kin-Cohort Study.
Conclusions:
- The competing risk framework effectively handles multiple, related events in kin-cohort studies.
- The extended composite-likelihood method offers improved and unbiased risk estimation for genetic mutation effects.
- This approach enhances the understanding of genetic risks for complex diseases like ovarian cancer.